Outcomes and prognoses of patients with ovarian cancer using bevacizumab: 6-year experience in a tertiary care hospital of northern Taiwan

PURPOSE: Bevacizumab (BEV) has been used for ovarian cancer (OC) for years in Taiwan, but the associated data related to outcome is scant. This retrospective study reviewed patients with OC treated with BEV and analyzed their results. PATIENTS AND METHODS: All patients with OC treated with BEV from...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei-Chun, Qiu, Jiantai Timothy, Lai, Chyong-Huey, Huang, Huei-Jean, Lin, Cheng-Tao, Chen, Min-Yu, Chou, Hung-Hsueh, Huang, Kuan-Gen, Chang, Ting-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415172/
https://www.ncbi.nlm.nih.gov/pubmed/28467466
http://dx.doi.org/10.1371/journal.pone.0175703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415172/
https://www.ncbi.nlm.nih.gov/pubmed/28467466
http://dx.doi.org/10.1371/journal.pone.0175703

Ejemplares similares